Showing 361 - 380 results of 122,292 for search '(( 5 ((((nn decrease) OR (mean decrease))) OR (a decrease)) ) OR ( 2 d decrease ))', query time: 1.92s Refine Results
  1. 361
  2. 362
  3. 363

    UVB irradiation decreased TM expression in HaCaT cells. by Huey-Chun Huang (429098)

    Published 2013
    “…<p>(A) HaCaT Cells were exposed to UVB irradiation in a dose-response (0, 1.5, 3, 4.5, 6 mJ/cm<sup>2</sup>) Cell viability was examined by trypan blue exclusion. …”
  4. 364
  5. 365
  6. 366
  7. 367
  8. 368

    Expression of SPDEF in prostate adenocarcinoma cells decreased prostate carcinogenesis in orthotopic model. by Xin-Hua Cheng (154368)

    Published 2014
    “…Mean weights of prostate glands (±SD) are shown (n = 10 for control TRAMP C2 cells, n = 5 for SPDEF OE cells). …”
  9. 369
  10. 370
  11. 371

    Damage accumulation decreases elongation rates and displaces growth equilibrium. by Audrey Menegaz Proenca (845486)

    Published 2019
    “…<p>All panels depict MG1655 wild-type <i>E</i>. <i>coli</i>. (A) Exposure to phototoxic damage led to decreasing elongation rates in all treatment levels (length of exposure, every 2 min: 70 ms, 700 ms, 1 s, 1.5 s, 3 s). …”
  12. 372

    Zinc exposure decreases NR1 clusters and NMDA currents. by Jia Zhu (135506)

    Published 2012
    “…(B) and (C) show the quantification of (A). Both the number and mean intensity of NR1 clusters were significantly decreased after zinc treatment. …”
  13. 373
  14. 374

    CXCL12 expression results in decreased proliferation of PDAC cells. by Ishan Roy (530438)

    Published 2014
    “…(C–D) Propidium Iodide cell cycle analysis revealed a decrease in percentage of cells in the G<sub>2</sub> phase in CXCL12-expressing cells compared to GFP controls. (*), (**), and (***) denote <i>P</i>≤0.05, <i>P</i>≤0.01, and <i>P</i>≤0.001 respectively in comparison to control cells (GFP). …”
  15. 375
  16. 376
  17. 377
  18. 378

    SPL decreases diabetes-induced oxidative stress in GL and PT. by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…SPL treatment prevents diabetes-induced increment in O<sub>2</sub><sup>●―</sup> production (A) by using nicotinamide adenine dinucleotide phosphate (NADPH) as substrate and, diphenyleneiodonium (DPI) as inhibitor, lipid peroxidation (B) and protein carbonylation (C) and decreased GSH content (D) in GL (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s003" target="_blank">S3 Fig</a>). …”
  19. 379
  20. 380